🔴 Hims Hers Health is trading 4.35% down today after sharply lower margins overshadowed higher revenue guidance

Hims Hers Health is trading 4.35% down at $30.39 after investors focused on the August 10 earnings miss and sharply lower margins.

• Second-quarter revenue reached $753.2 million, while the company reported a $0.37 loss per share.
• Gross margin fell to 64% amid the shift toward branded GLP-1 medications.
• Reuters reported shares fell nearly 7% premarket as margin concerns outweighed subscriber growth and higher revenue guidance.